[1]
|
D. T. Chen, Y.-L. Hsu, W. J. Fulp, et al., “Prognostic and Predictive Value of a Malignancy-Risk Gene Signature in Early-Stage Non-Small Cell Lung Cancer,” Journal of the National Cancer Institute, Vol. 103, No. 24, 2011, pp. 1859-1870. http://dx.doi.org/10.1093/jnci/djr420
|
[2]
|
T. A. D’Amico, M. Massey, J. E. Herndon, et al., “A Biologic Risk Model for Stage I Lung Cancer: Immunohistochemical Analysis of 408 Patients with the Use of Ten Molecular Markers,” The Journal of Thoracic and Cardiovascular Surgery, Vol. 117, No. 4, 1999, pp. 736-743. http://dx.doi.org/10.1016/ S0022-5223(99)70294-1
|
[3]
|
K. Konopa, “Do We Have Markers to Select Patients for Adjuvant Therapies of Non-Small-Cell Lung Cancer?” Annals of Oncology, Vol. 21, No. 7, 2010, pp. 199-202.
|
[4]
|
S. Y. Park, H. S. Lee, H. J. Jang, et al., “Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer,” The Annals of Thoracic Surgery, Vol. 91, No. 6, 2011, pp. 1668-1673.
http://dx.doi.org/10.1016/j.athoracsur.2010.12.028
|
[5]
|
B. A. Williams, H. Sugimura, Ch. Endo, et al., “Predicting Postrecurrence Survival Among Completely Resected Nonsmall-Cell Lung Cancer Patients,” The Annals of Thoracic Surgery, Vol. 81, No. 3, 2006, pp. 1021-1027.
http://dx.doi.org/10.1016/j.athoracsur.2005.09.020
|
[6]
|
W. Hilbe, S. Dirnhofer, F. Oberwasserlechner, et al., “Immunohistochemical Typing of Non-Small Cell Lung Cancer on Cryostat Sections: Correlation with Clinical Parameters and Prognosis,” Journal of Clinical Pathology, Vol. 56, No. 10, 2003, pp. 736-741.
http://dx.doi.org/10.1136/jcp.56.10.736
|
[7]
|
D. J. Raz, M. R. Ray, J. Y. Kim, et al., “A Multigene Assay Is Prognostic of Survival in Patients with EarlyStage Lung Adenocarcinoma,” Clinical Cancer Research, Vol. 14, No. 17, 2008, pp. 5565-5570.
http://dx.doi.org/10.1158/1078-0432.CCR-08-0544
|
[8]
|
C. Lu, J.-Ch. Soria, X. Tang, et al., “Prognostic Factors in Resected Stage I Non-Small-Cell Lung Cancer: A Multivariate Analysis of Six Molecular Markers,” Journal of Clinical Oncology, Vol.22, No. 22, 2004, pp. 4575-4583.
http://dx.doi.org/10.1200/JCO.2004.01.091
|
[9]
|
D. H. Harpole, Jr. J. E. Herndon, W. G. Wolfe, et al., “A Prognostic Model of Recurrence and Death in Stage I Non-Small Cell Lung Cancer Utilizing Presentation, Histopathology, and Oncoprotein Expression,” Cancer Research, Vol. 55, No. 1, 1995, pp. 51-56.
|
[10]
|
S. Holdenrieder, D. Nagel, V. Heinemann, et al., “Predictive and Prognostic Biomarker Models in Advanced Lung Cancer,” Journal of Clinical Oncology, Vol. 26, No. 15S, 2008, p. 19010.
|
[11]
|
A. Lopez-Encuentra, Lopez-Rios, E. Conde et al., “Composite Anatomical-Clinical-Molecular Prognostic Model in Nonsmall Cell Lung Cancer,” European Respiratory Journal, Vol. 31, No. 7, 2011, pp. 136-142.
http://dx.doi.org/10.1183/09031936.00028610
|
[12]
|
A. Petrie, C. Sabin, “Medical Statistics at a Glance,” In: Petrie A., Sabin C., Eds., Medical Statistics at a Glance, 2nd Edition, Blackwell Publishing, Malden, 2005.
|
[13]
|
S. Haykin, “Neural networks. A Comprehensive Foundation,” In: Haykin Simon, Ed., Neural Networks. A Comprehensive Foundation, 2nd Edition, Prentice Hall, Upper Saddle River, 1999.
|
[14]
|
C. Q. Zhu, W. Shih, C. H Ling and M. S. Tsao, “Immunohistochemical Markers of Prognosis in Non-Small Cell Lung Cancer: A Review and Proposal for a Multiphase Approach to Marker Evaluation,” Journal of Clinical Pathology, Vol. 59, No. 8, 2006, pp. 790-800.
http://dx.doi.org/10.1136/jcp.2005. 031351
|
[15]
|
L. R. Leonardus, van der Pijl, O. Birim, et al., “Validation of a Prognostic Model to Predict Survival after NonSmall-Cell Lung Cancer Surgery,” European Journal of Cardio-Thoracic Surgery, Vol. 38, No. 5, 2010, pp. 615-620. http://dx.doi.org/10.1016/j.ejcts.2010.03.028
|
[16]
|
H. Dosaka-Akita, F. Hommura, T. Mishina, et al., “A Risk-Stratification Model of Non-Small Cell Lung Cancers Using Cyclin E, Ki-67, and rasp21: Different Roles of G1 Cyclins in Cell Proliferation and Prognosis,” Cancer Research, Vol. 61, 2001, pp. 2500-2504.
|
[17]
|
L. Rubio, F. J. Vera-Sempere, J. A. Lopez-Guerrero, et al., “A Risk Model for Non-Small Cell Lung Cancer Using Clinicopathological Variables, Angiogenesis and Oncoprotein Expression,” Anticancer Research, Vol. 25, No. 1B, 2005, pp. 497-504.
|